Login / Signup

An Overview on Immunogenic Cell Death in Cancer Biology and Therapy.

Mosar Corrêa RodriguesJosé Athayde Vasconcelos MoraisRayane GanassinGiulia Rosa Tavares OliveiraFabiana Chagas CostaAmanda Alencar Cabral MoraisAriane Pandolfo SilveiraVictor Carlos Mello SilvaJoão Paulo Figueiró LongoLuis Alexandre Muehlmann
Published in: Pharmaceutics (2022)
Immunogenic cell death (ICD) is a modality of regulated cell death that is sufficient to promote an adaptive immune response against antigens of the dying cell in an immunocompetent host. An important characteristic of ICD is the release and exposure of damage-associated molecular patterns, which are potent endogenous immune adjuvants. As the induction of ICD can be achieved with conventional cytotoxic agents, it represents a potential approach for the immunotherapy of cancer. Here, different aspects of ICD in cancer biology and treatment are reviewed.
Keyphrases